Equity Analysis /
United States of America

US : Gilead Sciences, Inc. - GILD | No Longer Believes in Remdesivir (IV) Outside the Hospital

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    13 April 2021
    Published by